Ayala Pharmaceuticals, Inc. Quarterly Common Stock, Shares Authorized from Q3 2010 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Ayala Pharmaceuticals, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q3 2010 to Q4 2023.
  • Ayala Pharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending December 31, 2023 was 170M shares, a 354% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 170M +133M +354% Dec 31, 2023 10-K 2024-04-16
Q3 2023 170M 0 0% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 170M 0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 170M 0 0% Mar 31, 2023 10-Q 2023-05-23
Q4 2022 37.5M -133M -78% Dec 31, 2022 10-K 2024-04-16
Q3 2022 170M 0 0% Oct 31, 2022 10-K 2023-02-10
Q2 2022 170M -130M -43.3% Jul 31, 2022 10-Q 2022-09-13
Q1 2022 170M 0 0% Apr 30, 2022 10-Q 2022-06-08
Q4 2021 170M 0 0% Jan 31, 2022 10-Q 2022-03-17
Q3 2021 170M 0 0% Oct 31, 2021 10-K 2023-02-10
Q2 2021 300M +130M +76.5% Jun 3, 2021 10-K 2022-02-14
Q1 2021 170M 0 0% Apr 30, 2021 10-Q 2022-09-13
Q4 2020 170M 0 0% Jan 31, 2021 10-Q 2021-03-16
Q3 2020 170M 0 0% Oct 31, 2020 10-K 2022-02-14
Q2 2020 170M 0 0% Jul 31, 2020 10-Q 2020-09-10
Q1 2020 170M 0 0% Apr 30, 2020 10-Q 2020-06-11
Q4 2019 170M 0 0% Jan 31, 2020 10-Q 2020-03-13
Q3 2019 170M 0 0% Oct 31, 2019 10-K 2021-01-22
Q2 2019 170M +75M +78.9% Jul 31, 2019 10-Q 2019-09-09
Q1 2019 170M +140M +467% Apr 30, 2019 10-Q 2019-06-10
Q4 2018 170M +105M +162% Jan 31, 2019 10-Q 2019-03-12
Q3 2018 170M +75M +78.9% Oct 31, 2018 10-K 2019-12-20
Q2 2018 95M +30M +46.2% Jul 31, 2018 10-Q 2018-09-10
Q1 2018 30M -35M -53.8% Mar 21, 2018 10-Q 2018-09-10
Q4 2017 65M 0 0% Jan 31, 2018 10-Q 2018-03-12
Q3 2017 95M +30M +46.2% Oct 31, 2017 10-K 2019-01-11
Q2 2017 65M 0 0% Jul 31, 2017 10-Q 2017-09-11
Q1 2017 65M 0 0% Apr 30, 2017 10-Q 2017-06-06
Q4 2016 65M +20M +44.4% Jan 31, 2017 10-Q 2017-03-10
Q3 2016 65M 0 0% Oct 31, 2016 10-K 2017-12-21
Q2 2016 65M +20M +44.4% Jul 31, 2016 10-Q 2016-09-08
Q1 2016 65M +20M +44.4% Apr 30, 2016 10-Q 2016-06-08
Q4 2015 45M 0 0% Jan 31, 2016 10-Q 2016-02-26
Q3 2015 65M +20M +44.4% Oct 31, 2015 10-K 2017-01-09
Q2 2015 45M 0 0% Jul 31, 2015 10-Q 2015-09-11
Q1 2015 45M +20M +80% Apr 30, 2015 10-Q 2015-06-15
Q4 2014 45M +20M +80% Jan 31, 2015 10-Q 2015-03-13
Q3 2014 45M 0 0% Oct 31, 2014 10-K 2016-01-08
Q2 2014 45M +20M +80% Jul 31, 2014 10-Q 2014-09-09
Q1 2014 25M -975M -97.5% Apr 30, 2014 10-Q 2014-06-10
Q4 2013 25M -975M -97.5% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 45M +20M +80% Oct 31, 2013 10-K 2015-01-06
Q2 2013 25M -475M -95% Jul 31, 2013 10-Q 2013-09-16
Q1 2013 1B +500M +100% Apr 30, 2013 10-Q 2013-06-14
Q4 2012 1B +500M +100% Jan 31, 2013 10-Q/A 2013-03-25
Q3 2012 25M -975M -97.5% Oct 31, 2012 10-K 2014-01-29
Q2 2012 500M 0 0% Jul 31, 2012 10-Q/A 2012-10-04
Q1 2012 500M Apr 30, 2012 10-Q/A 2012-10-18
Q4 2011 500M Jan 31, 2012 10-Q/A 2012-10-18
Q3 2011 1B +500M +100% Oct 31, 2011 10-K/A 2013-02-14
Q2 2011 500M Jul 31, 2011 10-Q 2011-09-12
Q3 2010 500M Oct 31, 2010 10-K 2012-01-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.